Analysis of adverse event reporting with casimersen: a pharmacovigilance study based on the United States food and drug administration adverse event reporting system database

Key Points

• The aim is to analyze adverse event reporting patterns related to casimersen using FAERS data.
• Analyzed the FAERS database for adverse event reports related to casimersen.
• Summarized reporting distributions by preferred terms and organ system categories.
• Evaluated time-to-onset characteristics of reported adverse events.
• Characterized the distribution of adverse event reports by type and affected organ systems.
• Identified temporal patterns in the onset of adverse events following casimersen use.